Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Andrés García Palomo"'
Autor:
Mireia Obón-Santacana, Anna Díez-Villanueva, Maria Henar Alonso, Gemma Ibáñez-Sanz, Elisabet Guinó, Ana López, Lorena Rodríguez-Alonso, Alfredo Mata, Ana García-Rodríguez, Andrés García Palomo, Antonio J. Molina, Montse Garcia, Gemma Binefa, Vicente Martín, Victor Moreno
Publikováno v:
BMC Medicine, Vol 19, Iss 1, Pp 1-11 (2021)
Abstract Background Different risk-based colorectal cancer (CRC) screening strategies, such as the use of polygenic risk scores (PRS), have been evaluated to improve effectiveness of these programs. However, few studies have previously assessed its u
Externí odkaz:
https://doaj.org/article/733185c3c65f446a9006a4acf155d6ce
Autor:
Mariana López Flores, Emiliano Honrado Franco, Luis Felipe Sánchez Cousido, Carlos Minguito-Carazo, Oscar Sanz Guadarrama, Laura López González, María Eva Vallejo Pascual, Antonio José Molina de la Torre, Andrés García Palomo, Ana López González
Publikováno v:
Cancers, Vol 14, Iss 18, p 4418 (2022)
Aldehyde dehydrogenase 1A1 (ALDH1A1) is a cancer stem cell (CSC) marker related to clinical outcomes in breast cancer (BC). The aim of this study was to analyze the relationship between ALDH1A1, programmed death ligand 1 (PD-L1) and tumor-infiltratin
Externí odkaz:
https://doaj.org/article/97d17aa7cff746efb73eb195104f1aff
Autor:
Lidia García Martínez, Marina Pollán Santamaría, Gonzalo López Abente, María Mercedes Sánchez Jacob, Andrés García Palomo, Raquel González Martínez, Emiliano Honrado Franco, Vicente Martín Sánchez
Publikováno v:
Revista Española de Salud Pública, Vol 88, Iss 2, Pp 261-269 (2014)
Fundamentos: El cáncer de mama es el más frecuente en las mujeres. El objetivo del presente estudio fue analizar la incidencia y distribución geográfica del cáncer de mama invasivo en el área de salud de León (ASL). Métodos: Estudio observaci
Externí odkaz:
https://doaj.org/article/e9d87234e44949c5ae7c96b743021633
Autor:
Carolina Méndez-Blanco, Flavia Fondevila, Paula Fernández-Palanca, Andrés García-Palomo, Jos van Pelt, Chris Verslype, Javier González-Gallego, José L. Mauriz
Publikováno v:
Cancers, Vol 15, Iss 23, p 5668 (2023)
In the original publication [...]
Externí odkaz:
https://doaj.org/article/df18589dcf6941a88d4653052b1d37e8
Autor:
Irene Delgado Sillero, Nerea Lopetegui Lia, Luis Felipe Sánchez Cousido, Mariam Rojas Piedra, Blanca Távara Silva, Maria Luisa Garrido Onecha, Soledad Medina Valdivieso, Nieves Alonso Horcajo, Cristina Díez Tascón, Ana López González, Carmen Castañón López, Manuela Pedraza Lorenzo, Andrés García Palomo, Vicente Martín, Pilar Diz Tain
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Introduction 10–16% of non-small cell lung cancer (NSCLC) cases have the epidermal growth factor receptor (EGFR) amplified and/or mutated. Studies show that EGFR tyrosine kinase inhibitors (TKIs) significantly prolong progression-free survival (PFS
Autor:
Mariana López Flores, Emiliano Honrado Franco, Luis Felipe Sánchez Cousido, Carlos Minguito Carazo, Oscar Sanz Guadarrama, Laura López González, María Eva Vallejo Pascual, Antonio José Molina de la Torre, Andrés García Palomo, Ana López González
Background: Cytoplasmatic expression of Aldehyde dehydrogenase 1 A1 (ALDH1A1) has been identified as a cancer stem cell marker and related to an unfavorable prognosis. However, nuclear expression of ALDH1A1 has not been described in breast cancer (BC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e8968b856ec1ba3ecfb953d331f11e5
https://doi.org/10.21203/rs.3.rs-1315325/v1
https://doi.org/10.21203/rs.3.rs-1315325/v1
Autor:
Maria Henar Alonso, Elisabet Guinó, Victor Moreno, Mireia Obón-Santacana, Alfredo Mata, Montse Garcia, Gemma Binefa, Lorena Rodríguez-Alonso, Ana M. López, Ana García-Rodríguez, Vicente Martín, Gemma Ibáñez-Sanz, Antonio J. Molina, Andrés García Palomo, Anna Díez-Villanueva
Publikováno v:
BMC Medicine
BMC Medicine, Vol 19, Iss 1, Pp 1-11 (2021)
Dipòsit Digital de la UB
Universidad de Barcelona
BMC Medicine, Vol 19, Iss 1, Pp 1-11 (2021)
Dipòsit Digital de la UB
Universidad de Barcelona
Background Different risk-based colorectal cancer (CRC) screening strategies, such as the use of polygenic risk scores (PRS), have been evaluated to improve effectiveness of these programs. However, few studies have previously assessed its usefulness
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::999741ab34aa79cce3408ad25ea966db
http://hdl.handle.net/2445/181317
http://hdl.handle.net/2445/181317
Autor:
Carolina Méndez-Blanco, José L. Mauriz, Flavia Fondevila, Andrés García-Palomo, Javier González-Gallego
Publikováno v:
Experimental & Molecular Medicine
Experimental and Molecular Medicine, Vol 50, Iss 10, Pp 1-9 (2018)
Experimental and Molecular Medicine, Vol 50, Iss 10, Pp 1-9 (2018)
Sorafenib, a multikinase inhibitor with antiproliferative, antiangiogenic, and proapoptotic properties, constitutes the only effective first-line drug approved for the treatment of advanced hepatocellular carcinoma (HCC). Despite its capacity to incr
Autor:
Juan de la Haba-Rodriguez, Laura Murillo, Manuel Ramos, Serafin Morales, Manuel Ruiz-Borrego, Mireia Margeli, Santiago González-Santiago, Eva Ciruelos, Christoph C. Zielinski, Miguel Gil-Gil, Begoña Bermejo, Lourdes Calvo, Graciela Rodrigálvarez, Emilio Alba, Andrés García-Palomo, Eva Carrasco, Montserrat Muñoz, Sonia Servitja, César A. Rodríguez, Antonio Antón, Tibor Csoszi, Isabel Álvarez López, Elena Salvador Álvarez, Einav Nili Gal-Yam, Miguel Martín, István Láng, Massimo Corsaro, Zsuzsanna Kahán, Maribel Casas
Publikováno v:
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Dipòsit Digital de la UB
Universidad de Barcelona
European journal of cancer (Oxford, England : 1990)
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Dipòsit Digital de la UB
Universidad de Barcelona
European journal of cancer (Oxford, England : 1990)
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
BACKGROUND: The PEARL study showed that palbociclib plus endocrine therapy (palbociclib/ET) was not superior to capecitabine in improving progression-free survival in postmenopausal patients with metastatic breast cancer resistant to aromatase inhibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee6ff39a8334e87390a0c51f56755729
http://zaguan.unizar.es/record/110834
http://zaguan.unizar.es/record/110834
Autor:
Andrés García-Palomo, Flavia Fondevila, Chris Verslype, José L. Mauriz, Carolina Méndez-Blanco, Jos van Pelt, Paula Fernández-Palanca, Javier González-Gallego
Publikováno v:
Cancers
Volume 11
Issue 12
Volume 11
Issue 12
Despite sorafenib effectiveness against advanced hepatocarcinoma (HCC), long-term exposure to antiangiogenic drugs leads to hypoxic microenvironment, a key contributor to chemoresistance acquisition. We aimed to study the role of hypoxia in the devel